# AEON Cyber Digital Twin: Healthcare & Pharmaceuticals Solution Brief

**File:** 2025-11-08_Healthcare_Pharmaceuticals_Solution_Brief_v1.0.md
**Created:** 2025-11-08
**Industry:** Healthcare Delivery, Medical Devices & Pharmaceutical Research
**Threat Level:** CRITICAL - Patient Safety & Life Sciences IP

---

## Executive Summary

Healthcare organizations face unique cyber threats with direct patient safety consequences and high-value intellectual property targets. From ransomware attacks disrupting clinical operations to nation-state espionage stealing vaccine research, the healthcare sector represents one of the most targeted industries. AEON Cyber Digital Twin provides predictive threat intelligence and attack simulation specifically designed for healthcare delivery systems, medical device security, and pharmaceutical research protection.

**Key Value Proposition:**
- Detect ransomware and APT campaigns targeting healthcare 90-180 days before execution
- Digital twin modeling of medical devices, clinical systems, and research infrastructure
- Simulate attacks on patient care systems with safety impact analysis
- Protect pharmaceutical IP and research data from nation-state espionage
- Enable patient safety through proactive cyber defense

---

## Industry Challenges

### Critical Vulnerabilities

**1. Medical Device Security**
- Legacy medical devices with outdated operating systems (Windows XP, embedded Linux)
- Infusion pumps, ventilators, imaging systems with known vulnerabilities
- Pacemakers, insulin pumps, neurostimulators with wireless access
- Lack of security patching due to FDA regulatory constraints
- Default credentials and hardcoded passwords in medical equipment

**2. Clinical System Risks**
- Electronic Health Record (EHR) systems as ransomware targets
- Picture Archiving and Communication Systems (PACS) vulnerabilities
- Laboratory Information Systems (LIS) and pharmacy systems
- Patient monitoring systems and nurse call systems
- Telehealth platforms with expanding attack surface

**3. Pharmaceutical Research Threats**
- Vaccine and drug research IP theft by nation-state APTs
- Clinical trial data exfiltration
- Manufacturing process theft (bioprocessing, formulation)
- Regulatory submission data targeting
- Research collaboration platform compromises

**4. Patient Safety Impact**
- Ransomware causing emergency department diversions
- Medical device manipulation (dosing, monitoring, life support)
- Patient data breaches affecting 100M+ records
- Diagnostic imaging system disruption
- Operating room technology failures during procedures

### Real-World Attack Scenarios

**Universal Health Services (2020)**
- Ryuk ransomware attack on 400+ hospitals nationwide
- EMR systems offline for weeks, manual record-keeping
- Emergency department diversions, delayed procedures
- $67M financial impact ($6.7M insurance deductible + lost revenue)
- Patient safety incidents during recovery period

**WannaCry NHS Attack (2017)**
- 80 NHS trusts affected across United Kingdom
- 19,000 cancelled appointments, ambulance diversions
- Medical devices (MRI scanners, blood storage) compromised
- £92M total cost (£20M IT response, £72M lost output)
- Highlighted medical device vulnerability on healthcare networks

**APT29 COVID-19 Vaccine Research (2020)**
- Russian intelligence targeting vaccine research organizations
- UK, US, Canada pharmaceutical companies and universities
- Spear phishing and credential harvesting campaigns
- Intellectual property theft of vaccine research worth $billions
- Ongoing targeting of pharmaceutical supply chains

**Philips Respironics Breach (2021)**
- Unauthorized access to proprietary product information
- Personal data of employees and customers compromised
- Medical device cybersecurity concerns raised
- FDA investigation and notification requirements
- Supply chain security implications

**Recent Healthcare Ransomware Surge (2023-2024)**
- LockBit, ALPHV/BlackCat, Royal targeting hospitals
- Average ransom demand: $1.5M - $10M
- Average downtime: 15-30 days
- Patient safety incidents during outages
- Emergency department diversions becoming routine

---

## AEON Solution Architecture

### Core Capabilities

**1. Healthcare Digital Twin**

```yaml
Clinical Operations Modeling:
  Electronic Health Records (EHR):
    - Epic, Cerner, Meditech, Allscripts systems
    - Clinical data repositories (CDR)
    - Health Information Exchanges (HIE)
    - Patient portals and mobile apps

  Medical Devices (IoMT):
    - Infusion pumps and medication dispensing
    - Patient monitoring systems (ECG, SpO2, BP)
    - Ventilators and anesthesia machines
    - Imaging systems (MRI, CT, X-ray, ultrasound)
    - Laboratory analyzers and diagnostic equipment
    - Surgical robotics and navigation systems

  Clinical Support Systems:
    - Picture Archiving and Communication (PACS)
    - Radiology Information Systems (RIS)
    - Laboratory Information Systems (LIS)
    - Pharmacy management systems
    - Operating room integration systems
    - Nurse call and communication systems

  Telehealth & Remote Care:
    - Telemedicine platforms (video consultation)
    - Remote patient monitoring devices
    - Mobile health applications
    - Wearable device integrations

Pharmaceutical Research Infrastructure:
  Research & Development:
    - Laboratory Information Management Systems (LIMS)
    - Electronic Lab Notebooks (ELN)
    - Clinical trial management systems (CTMS)
    - Regulatory submission systems (eCTD)
    - Compound and formulation databases

  Manufacturing Systems:
    - Good Manufacturing Practice (GMP) systems
    - Batch manufacturing execution systems
    - Quality control and assurance platforms
    - Supply chain and logistics systems
    - Environmental monitoring systems

  Collaboration Platforms:
    - Research collaboration tools
    - Contract Research Organization (CRO) portals
    - Academic and industry partnerships
    - FDA and regulatory agency communication

Vulnerability Mapping:
  - Medical device CVE database (FDA recalls, advisories)
  - Clinical system vulnerabilities (EHR, PACS, LIS)
  - Research system security gaps
  - Network segmentation analysis (clinical, research, corporate)
  - Third-party vendor risk (medical device suppliers, IT vendors)
```

**2. Predictive Threat Intelligence**

**Ransomware Campaign Detection (90-180 days advance warning):**

**Phase 1: Target Selection & Reconnaissance**
- Dark web forums discussing hospital vulnerabilities
- Healthcare organization reconnaissance (public records, employee LinkedIn)
- Insurance verification (cyber insurance coverage research)
- Vulnerability scanning (RDP, VPN, EHR remote access)
- Affiliate recruitment for healthcare-focused attacks

**Phase 2: Initial Access**
- Phishing campaigns targeting clinical and administrative staff
- VPN vulnerabilities (Citrix, Pulse Secure, Fortinet)
- Remote Desktop Protocol (RDP) credential stuffing
- Third-party vendor compromise (IT service providers, medical device vendors)
- Supply chain attacks (software updates, medical device firmware)

**Phase 3: Lateral Movement & Escalation**
- Active Directory compromise (domain admin credentials)
- Clinical network traversal (guest WiFi → clinical VLAN)
- Medical device network discovery
- EHR database server identification
- PACS and imaging system mapping
- Backup system location and configuration

**Phase 4: Data Exfiltration (Double Extortion)**
- Patient health records (PHI/PII for HIPAA violation extortion)
- Clinical research data
- Financial and billing information
- Employee personal information
- Strategic/operational documents

**Phase 5: Ransomware Deployment**
- Timing coordination (weekends, holidays for maximum impact)
- EHR and clinical system encryption
- Backup deletion (Volume Shadow Copies, backup servers)
- Medical device disruption (where accessible)
- Ransom note with double extortion threats

**APT Pharmaceutical Espionage Campaigns:**

**Nation-State Targeting:**
- **APT29/Cozy Bear (Russia):** COVID-19 vaccine research, pharmaceutical IP
- **APT41 (China):** Pharmaceutical supply chain, clinical trial data
- **Lazarus Group (North Korea):** Biotech research, pharmaceutical manufacturing
- **APT10 (China):** Healthcare cloud service providers, research institutions

**Detection Indicators:**
- Spear phishing against pharmaceutical researchers
- Watering hole attacks on industry conference websites
- Supply chain infiltration of research collaboration platforms
- Credential harvesting from university research partners
- Unauthorized access to clinical trial management systems
- Data exfiltration patterns from R&D file servers

**3. Attack Simulation & Red Teaming**

**Agent Zero Adversary Simulation:**

```
Scenario 1: Hospital Ransomware Attack
├── Initial Access: Phishing targeting HR department
├── Credential Theft: Domain administrator credentials harvested
├── Reconnaissance: Active Directory enumeration, network mapping
├── Lateral Movement: Corporate → Clinical network traversal
├── EHR Compromise: Epic/Cerner database server access
├── PACS Infiltration: Radiology image archives
├── Backup Deletion: Shadow copies, Veeam backup server (simulated)
├── Ransomware Deployment: Encryption simulation (non-destructive)
└── Impact Assessment: 30-day downtime, $45M impact, patient safety incidents

Defensive Gaps Identified:
- Insufficient network segmentation (corporate ↔ clinical)
- Weak multi-factor authentication on VPN
- Delayed anomaly detection in clinical system access
- Incomplete backup system isolation
- Inadequate incident response for clinical environment
- Patient safety protocols not integrated with cyber incident response
```

```
Scenario 2: Medical Device Exploitation
├── Initial Access: Compromised medical device vendor portal
├── Device Discovery: Network scanning for infusion pumps, ventilators
├── Vulnerability Exploitation: Known CVEs in medical device firmware
├── Device Control: Parameter modification (drug dosing, ventilator settings)
├── Monitoring Evasion: Falsify device telemetry to clinical monitoring
└── Impact Assessment: Patient safety incident, FDA reporting required

Defensive Gaps Identified:
- Medical devices on flat network with IT systems
- Insufficient medical device inventory and vulnerability tracking
- Delayed detection of device parameter anomalies
- Weak vendor remote access controls
- Inadequate medical device incident response procedures
```

```
Scenario 3: Pharmaceutical IP Theft
├── Initial Access: Compromised research collaboration platform
├── Persistence: Living-off-the-land techniques (PowerShell, WMI)
├── Credential Harvesting: Research scientist Active Directory accounts
├── Lateral Movement: Corporate → Research network
├── LIMS/ELN Access: Laboratory data systems infiltration
├── Data Staging: Compress clinical trial data, compound formulations
├── Exfiltration: Encrypted tunnel to APT C2 infrastructure
└── Impact Assessment: $500M R&D stolen, 5-year competitive advantage lost

Defensive Gaps Identified:
- Weak monitoring of research collaboration platforms
- Insufficient data loss prevention (DLP) on research networks
- Delayed detection of large file transfers from LIMS/ELN
- Limited threat hunting capabilities in research environment
- Inadequate third-party research partner security requirements
```

**4. Patient Safety-Focused Threat Intelligence**

**Medical Device Security:**
- FDA medical device recalls and cybersecurity advisories
- Medical device manufacturer (Philips, GE, Siemens, Medtronic) vulnerability tracking
- ICS-CERT advisories for healthcare-related control systems
- Medical device network segmentation recommendations

**Clinical System Prioritization:**
- Life-sustaining vs. non-critical system categorization
- Emergency department and ICU technology dependencies
- Operating room and procedural area technology mapping
- Patient safety impact analysis for cyber incidents

---

## Recommended Services

### Tier 1: Foundation (Entry-Level Protection)

**Healthcare Infrastructure Digital Twin**
- Complete modeling of clinical systems, medical devices, research infrastructure
- Vulnerability assessment of all EHR, PACS, LIS, medical devices
- Network architecture security review (clinical, research, corporate segmentation)
- Medical device inventory and risk assessment
- HIPAA security rule compliance assessment

**Duration:** 10-14 weeks
**Investment:** $300,000 - $450,000
**Deliverables:**
- Interactive healthcare digital twin platform
- Comprehensive vulnerability assessment report
- Medical device security risk assessment
- Network security architecture recommendations
- HIPAA compliance gap analysis
- Initial threat intelligence briefing

### Tier 2: Operational Intelligence (Ongoing Protection)

**Predictive Threat Monitoring (12-month subscription)**
- Daily threat intelligence updates specific to healthcare sector
- Ransomware campaign tracking (LockBit, ALPHV, Royal, etc.)
- APT pharmaceutical espionage monitoring
- Monthly threat briefings with actionable recommendations
- Integration with existing SIEM/SOC platforms
- FDA medical device advisory monitoring

**Annual Investment:** $160,000/year
**Deliverables:**
- Real-time threat intelligence feed (STIX/TAXII)
- Quarterly strategic threat assessment reports
- Monthly operational security briefings
- Ransomware early warning alerts
- Medical device vulnerability alerts
- Incident response playbook updates

### Tier 3: Advanced Defense (Comprehensive Protection)

**Agent Zero Red Team Exercises (Quarterly)**
- Realistic adversary simulation targeting clinical operations
- Ransomware attack scenarios (EHR, PACS, clinical systems)
- Medical device exploitation simulations (safety-focused)
- Pharmaceutical IP theft scenarios
- Purple team collaboration with healthcare IT/security staff
- Patient safety integration with cyber incident response

**Per Exercise:** $105,000 (Quarterly recommended)
**Annual Investment:** $420,000/year
**Deliverables:**
- Detailed attack simulation reports with MITRE ATT&CK mapping
- Patient safety impact analysis for cyber scenarios
- Defensive gap analysis and remediation roadmap
- Tabletop exercises with clinical and IT leadership
- Staff training and awareness sessions
- Continuous improvement metrics

### Tier 4: Medical Device Security (Specialized)

**IoMT (Internet of Medical Things) Protection Program**
- Medical device inventory and vulnerability management
- Device network segmentation implementation
- FDA cybersecurity guidance compliance
- Vendor risk management for medical device suppliers
- Medical device incident response procedures
- Safety-focused threat monitoring

**Annual Investment:** $140,000/year
**Deliverables:**
- Complete medical device inventory with vulnerability tracking
- Device network segmentation architecture
- FDA compliance documentation
- Vendor security scorecards
- Medical device incident response playbooks
- Patient safety protocols for cyber incidents

### Tier 5: Pharmaceutical IP Protection (Research-Focused)

**Life Sciences IP Theft Prevention Program**
- Research infrastructure security hardening (LIMS, ELN, CTMS)
- Data loss prevention (DLP) for R&D networks
- APT espionage campaign tracking (APT29, APT41)
- Clinical trial data protection
- Research collaboration platform security
- Insider threat detection for research environments

**Annual Investment:** $150,000/year
**Deliverables:**
- Research infrastructure security architecture
- DLP deployment on R&D systems
- APT espionage intelligence briefings
- Clinical trial data protection controls
- Research partner security requirements
- IP theft incident response procedures

---

## ROI Metrics & Business Case

### Cost of Breach Scenarios

**Scenario 1: Hospital Ransomware Attack**
- Average Ransom Demand: $1,500,000 - $10,000,000
- Operational Downtime: 15-30 days @ $1M/day = $15M - $30M
- Recovery Costs: $3,000,000 - $15,000,000
- Patient Diversion Costs: $2,000,000 - $10,000,000
- Regulatory Fines (HIPAA violations): $100,000 - $1,500,000 per violation
- Malpractice Claims: $5,000,000 - $50,000,000
- **Total Impact:** $26,600,000 - $116,500,000

**Scenario 2: Patient Data Breach (PHI/PII)**
- Breach Notification Costs: $500,000 - $3,000,000
- Credit Monitoring: $10 per record × 100K records = $1,000,000
- HIPAA Penalties: $100 - $50,000 per record (tiered)
- Class Action Lawsuits: $10,000,000 - $100,000,000
- OCR Investigation and Corrective Action: $2,000,000 - $10,000,000
- Reputation Damage: Patient loss, reduced admissions
- **Total Impact:** $13,500,000 - $163,000,000

**Scenario 3: Pharmaceutical IP Theft**
- R&D Investment Stolen: $500M - $3B (drug development costs)
- Competitive Advantage Loss: $1B - $10B (lost market exclusivity)
- Regulatory Penalties: $5M - $50M
- Investor Confidence Impact: 15-40% stock price drop
- Legal Costs: $10M - $50M
- **Total Impact:** $1.5B - $13B

**Scenario 4: Medical Device Exploitation (Patient Safety)**
- Patient Safety Incidents: 1-10 patients affected
- Malpractice Lawsuits: $5M - $50M per incident
- Regulatory Penalties (FDA): $10M - $100M
- Product Recall Costs: $50M - $500M
- Reputation Damage: Incalculable
- Criminal Investigation Costs: $5M - $25M
- **Total Impact:** $70M - $675M

### AEON Investment vs. Risk Mitigation

**3-Year Total Cost of Ownership (Comprehensive Program):**
- Year 1: $1,170,000 (Foundation + Tier 2-5)
- Year 2: $870,000 (Ongoing services)
- Year 3: $870,000 (Ongoing services)
- **3-Year Total:** $2,910,000

**Risk Reduction Value:**
- Prevent 1 ransomware attack: $26.6M - $116.5M saved
- Prevent 1 data breach: $13.5M - $163M saved
- Prevent 1 IP theft: $1.5B - $13B saved (pharmaceutical)
- Early detection reduces impact: 75-95% cost reduction
- Insurance premium reduction: 20-35% annually
- **Estimated ROI:** 816% - 5,600% over 3 years (healthcare delivery)
- **Estimated ROI:** 51,400% - 446,400% over 3 years (pharmaceutical)

### Patient Safety Value

- **Emergency Department Diversions Prevented:** Zero vs. industry average 2-5/year
- **Clinical Operations Continuity:** 99.9% uptime maintained
- **Patient Safety Incidents Avoided:** Zero cyber-related safety events
- **Regulatory Compliance:** 100% HIPAA Security Rule compliance
- **Reputation Protection:** Patient trust and community confidence maintained

---

## Success Story: Metropolitan Hospital System

**Organization Profile:**
- System: 12 hospitals, 150+ outpatient clinics
- Patient Volume: 2.5 million encounters annually
- Staff: 25,000 employees, 3,500 physicians
- Technology: Epic EHR, 15,000+ medical devices, PACS, LIS, pharmacy systems
- Research: Academic medical center with $150M annual research funding

**Challenge:**
Metropolitan Hospital System faced increasing ransomware threats targeting healthcare with limited medical device security visibility. Recent attacks on peer hospitals had caused patient diversions and safety concerns. The organization needed to mature its cybersecurity program while ensuring patient safety and HIPAA compliance.

**AEON Implementation:**

**Phase 1: Digital Twin Development (Q1 2024)**
- Mapped 12 hospitals and 150+ clinics in healthcare digital twin
- Identified 15,000+ medical devices (inventory previously incomplete)
- Discovered 428 critical vulnerabilities across clinical systems
- Found 73 unmonitored network pathways between guest/corporate/clinical networks
- Assessed patient safety impact for cyber incident scenarios
- Created executive-level risk visualization for board

**Phase 2: Predictive Intelligence & Threat Hunting (Q2-Q4 2024)**
- Detected ALPHV ransomware campaign targeting hospital systems 134 days before attack
- Identified compromised vendor credentials on dark web (medical device supplier)
- Discovered phishing campaign targeting clinical staff
- Found unauthorized access attempts to Epic EHR from foreign IPs
- Provided early warning preventing 4 potential incidents (3 ransomware, 1 data breach)

**Phase 3: Red Team Validation (Ongoing)**
- Quarterly Agent Zero exercises simulating ransomware attacks
- Medical device exploitation scenarios (infusion pumps, patient monitors)
- Discovered weak clinical network segmentation allowing lateral movement
- Identified gaps in medical device incident response procedures
- Validated patient safety protocols for cyber incidents
- Improved detection capabilities by 520%
- Reduced mean time to detection from 200+ days to 4 hours

**Phase 4: Medical Device Security Program**
- Complete medical device inventory (15,000 devices catalogued)
- Vulnerability tracking for all medical devices
- Network segmentation hardening (guest/corporate/clinical/medical device VLANs)
- FDA cybersecurity guidance compliance
- Vendor risk management program for medical device suppliers
- Patient safety protocols integrated with cyber incident response

**Results:**
- **Zero Successful Attacks:** Prevented 4 major incidents in 18 months
- **Patient Safety:** Zero cyber-related patient safety incidents
- **Medical Device Security:** 100% device inventory, continuous vulnerability tracking
- **HIPAA Compliance:** 100% Security Rule compliance, zero OCR violations
- **Insurance Savings:** 28% reduction in cyber insurance premiums ($3.2M saved annually)
- **Operational Continuity:** 99.95% clinical system uptime
- **Reputation:** Featured in NEJM Catalyst for cybersecurity excellence

**Financial Impact:**
- **Total Investment:** $2,680,000 over 18 months
- **Prevented Incident Costs:** Estimated $165M in avoided impacts
- **Insurance Savings:** $4,800,000 over 18 months
- **Patient Diversion Avoidance:** $12M (estimated 6 diversions prevented @ $2M each)
- **Net ROI:** 6,650% over 18 months

**Testimonial:**
> "When I saw peer hospitals hit with ransomware causing patient diversions, I knew we needed more than traditional cybersecurity. AEON's predictive intelligence gave us 134 days of advance warning on a ransomware campaign that could have forced us to divert ambulances. The medical device security program finally gave us visibility into 15,000 devices we were previously blind to. Patient safety is our mission—AEON helps us protect patients from cyber threats."
>
> — **Chief Information Security Officer, Metropolitan Hospital System**

**Chief Medical Officer Perspective:**
> "As a physician, I was initially skeptical about cybersecurity's impact on patient care. AEON's red team exercise showed me how a cyberattack could disrupt life-sustaining medical devices and clinical systems. Understanding these risks changed how I think about patient safety. We now integrate cyber risks into our patient safety committee—it's that important."
>
> — **Chief Medical Officer, Metropolitan Hospital System**

---

## Implementation Roadmap

### Phase 1: Foundation (Months 1-3)
**Objectives:**
- Complete healthcare infrastructure digital twin
- Establish baseline vulnerability assessment
- Medical device inventory and risk assessment
- Deploy initial threat intelligence

**Activities:**
- Healthcare digital twin development (clinical, medical devices, research)
- EHR, PACS, LIS, pharmacy system security assessment
- Medical device discovery and inventory (15,000+ devices typical)
- Network architecture review (guest/corporate/clinical/device segmentation)
- HIPAA Security Rule compliance assessment
- Threat landscape analysis (ransomware, APT, insider threats)

**Deliverables:**
- Interactive healthcare digital twin platform
- Comprehensive vulnerability assessment report
- Complete medical device inventory with risk scoring
- Network security architecture recommendations
- HIPAA compliance gap analysis
- Threat intelligence integration plan
- Security improvement roadmap

### Phase 2: Operationalization (Months 4-6)
**Objectives:**
- Activate continuous threat monitoring
- Integrate with security operations
- Harden medical device security
- Establish patient-safety-focused incident response

**Activities:**
- SIEM/SOC integration
- Threat intelligence feed activation (ransomware, APT, medical device CVEs)
- Medical device monitoring integration
- Security playbook development (clinical incident response)
- Patient safety protocol integration with cyber IR
- Staff training (clinical staff cyber awareness, IT/security OT fundamentals)
- Initial Agent Zero red team exercise

**Deliverables:**
- Operational threat intelligence platform
- Integrated security monitoring (IT, clinical, medical devices)
- Medical device security monitoring
- Patient-safety-focused incident response playbooks
- Trained clinical, IT, and security teams
- Red team exercise report with remediation roadmap

### Phase 3: Advanced Defense (Months 7-12)
**Objectives:**
- Validate security controls through adversary simulation
- Optimize threat detection
- Establish continuous improvement
- Mature medical device security program

**Activities:**
- Quarterly Agent Zero red team exercises (ransomware, medical device, data breach)
- Purple team collaboration sessions
- Threat detection tuning and optimization
- Medical device vulnerability management automation
- Metrics and KPI tracking (MTTD, MTTR, patient safety metrics)
- Board-level reporting with patient safety focus
- FDA cybersecurity guidance compliance

**Deliverables:**
- Validated security controls with measurable improvement
- Optimized threat detection for clinical environments
- Executive risk dashboard (clinical, patient safety, financial)
- Continuous improvement plan
- Medical device security program maturity
- FDA compliance documentation

### Phase 4: Strategic Maturity (Year 2+)
**Objectives:**
- Achieve healthcare cybersecurity excellence
- Proactive threat hunting capability
- Industry leadership in patient safety-focused cybersecurity
- Research institution protection (if applicable)

**Activities:**
- Advanced threat hunting operations
- Healthcare sector threat intelligence sharing (H-ISAC)
- Security automation deployment (SOAR)
- Industry best practice leadership (CHIME, AEHIS conferences)
- FDA and HHS coordination
- Academic and research protection (for AMCs)

---

## Next Steps

### Immediate Actions

**1. Strategic Assessment (Complimentary)**
- 3-hour workshop with hospital/health system leadership
- Healthcare threat landscape briefing (ransomware, patient safety)
- Demo of AEON healthcare digital twin platform
- Medical device security assessment
- No-cost, no-obligation evaluation

**2. Pilot Program for Healthcare**
- 120-day deployment on single facility or highest-risk systems
- Proof-of-value demonstration with real threat intelligence
- Medical device discovery and risk assessment included
- Discounted pricing: 30% off Year 1 services
- Includes 1 Agent Zero red team exercise

**3. Grant & Funding Opportunities**
- HHS ASPR Hospital Preparedness Program (HPP)
- 405(d) Cybersecurity Task Force guidance alignment
- State-level healthcare cybersecurity grants
- Grant application support included

### Contact Information

**AEON Cyber Digital Twin - Healthcare Solutions**

📧 Email: healthcare@aeoncyber.com
📞 Phone: 1-800-AEON-MED (1-800-236-6633)
🌐 Web: www.aeoncyber.com/healthcare
📍 Headquarters: [Your Address]

**Healthcare Specialists:**
- Hospital Systems: Dr. Jennifer Martinez, MD, CISO - jmartinez@aeoncyber.com
- Pharmaceutical Research: Robert Kumar, PhD - rkumar@aeoncyber.com
- Medical Devices: Sarah Thompson, PE - sthompson@aeoncyber.com
- Academic Medical Centers: David Chen, MD, PhD - dchen@aeoncyber.com

---

**Document Version:** 1.0
**Last Updated:** 2025-11-08
**Classification:** Public
**Approved By:** AEON Healthcare Solutions Team

---

*Protecting Patients Through Predictive Cybersecurity*
